Literature DB >> 30618052

Emerging insights from the genetics of cerebral small-vessel disease.

Loes C A Rutten-Jacobs1, Natalia S Rost2.   

Abstract

Cerebral small-vessel disease (cSVD) is a common cause of stroke, functional decline, vascular cognitive impairment, and dementia. Pathological processes in the brain's microcirculation are tightly interwoven with pathology in the brain parenchyma, and this interaction has been conceptualized as the neurovascular unit (NVU). Despite intensive research efforts to decipher the NVU's structure and function to date, molecular mechanisms underlying cSVD remain poorly understood, which hampers the development of cSVD-specific therapies. Important steps forward in understanding the disease mechanisms underlying cSVD have been made using genetic approaches in studies of both monogenic and sporadic SVD. We provide an overview of the NVU's structure and function, the implications for cSVD, and the underlying molecular mechanisms of dysfunction that have emerged from recent genetic studies of both monogenic and sporadic diseases of the small cerebral vasculature.
© 2019 New York Academy of Sciences.

Entities:  

Keywords:  cerebral small-vessel disease; genetics; neurovascular unit; stroke

Mesh:

Year:  2019        PMID: 30618052      PMCID: PMC6614021          DOI: 10.1111/nyas.13998

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  91 in total

1.  Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study.

Authors:  I Akiguchi; H Tomimoto; T Suenaga; H Wakita; H Budka
Journal:  Acta Neuropathol       Date:  1998-01       Impact factor: 17.088

2.  Early-onset stroke and vasculopathy associated with mutations in ADA2.

Authors:  Qing Zhou; Dan Yang; Amanda K Ombrello; Andrey V Zavialov; Camilo Toro; Anton V Zavialov; Deborah L Stone; Jae Jin Chae; Sergio D Rosenzweig; Kevin Bishop; Karyl S Barron; Hye Sun Kuehn; Patrycja Hoffmann; Alejandra Negro; Wanxia L Tsai; Edward W Cowen; Wuhong Pei; Joshua D Milner; Christopher Silvin; Theo Heller; David T Chin; Nicholas J Patronas; John S Barber; Chyi-Chia R Lee; Geryl M Wood; Alexander Ling; Susan J Kelly; David E Kleiner; James C Mullikin; Nancy J Ganson; Heidi H Kong; Sophie Hambleton; Fabio Candotti; Martha M Quezado; Katherine R Calvo; Hawwa Alao; Beverly K Barham; Anne Jones; James F Meschia; Bradford B Worrall; Scott E Kasner; Stephen S Rich; Raphaela Goldbach-Mansky; Mario Abinun; Elizabeth Chalom; Alisa C Gotte; Marilynn Punaro; Virginia Pascual; James W Verbsky; Troy R Torgerson; Nora G Singer; Timothy R Gershon; Seza Ozen; Omer Karadag; Thomas A Fleisher; Elaine F Remmers; Shawn M Burgess; Susan L Moir; Massimo Gadina; Raman Sood; Michael S Hershfield; Manfred Boehm; Daniel L Kastner; Ivona Aksentijevich
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

3.  Stroke genome-wide association studies: the large numbers imperative.

Authors:  James F Meschia
Journal:  Stroke       Date:  2010-02-25       Impact factor: 7.914

4.  Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Tom Den Heijer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

5.  Analysis of genetic variability and whole genome linkage of whole-brain, subcortical, and ependymal hyperintense white matter volume.

Authors:  Peter Kochunov; David Glahn; Anderson Winkler; Ravindranath Duggirala; Rene L Olvera; Shelley Cole; Thomas D Dyer; Laura Almasy; Peter T Fox; John Blangero
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

6.  HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins.

Authors:  Chio Oka; Rumi Tsujimoto; Miwa Kajikawa; Kazuko Koshiba-Takeuchi; Junko Ina; Masato Yano; Akiho Tsuchiya; Yoshihumi Ueta; Akinobu Soma; Hidenobu Kanda; Michio Matsumoto; Masashi Kawaichi
Journal:  Development       Date:  2004-03       Impact factor: 6.868

7.  Genetic variation in white matter hyperintensity volume in the Framingham Study.

Authors:  Larry D Atwood; Philip A Wolf; Nancy L Heard-Costa; Joseph M Massaro; Alexa Beiser; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-05-13       Impact factor: 7.914

8.  The neurovascular unit in health and disease: introduction.

Authors:  Eng H Lo; Gary A Rosenberg
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

Review 9.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.

Authors:  Debbie S Kuo; Cassandre Labelle-Dumais; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

10.  Genetic Study of White Matter Integrity in UK Biobank (N=8448) and the Overlap With Stroke, Depression, and Dementia.

Authors:  Loes C A Rutten-Jacobs; Daniel J Tozer; Marco Duering; Rainer Malik; Martin Dichgans; Hugh S Markus; Matthew Traylor
Journal:  Stroke       Date:  2018-05-11       Impact factor: 7.914

View more
  3 in total

Review 1.  Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management.

Authors:  Maria Clara Zanon Zotin; Lukas Sveikata; Anand Viswanathan; Pinar Yilmaz
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 6.283

2.  Correlation of Serum C-Peptide, Soluble Intercellular Adhesion Molecule-1, and NLRP3 Inflammasome-Related Inflammatory Factor Interleukin-1β after Brain Magnetic Resonance Imaging Examination with Cerebral Small Vessel Disease.

Authors:  Chunli Ma; Lei Yang; Lihua Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-01-27       Impact factor: 3.161

Review 3.  Report of two pedigrees with heterozygous HTRA1 variants-related cerebral small vessel disease and literature review.

Authors:  Hui Zhou; Bin Jiao; Ziyu Ouyang; Qihui Wu; Lu Shen; Liangjuan Fang
Journal:  Mol Genet Genomic Med       Date:  2022-08-10       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.